Abstract
Introduction The number of people living with dementia is increasing worldwide. Alzheimer’s disease (AD) is the most common type of dementia. It typically manifests itself initially with cognitive impairment in the memory domain, and gradually progresses towards affecting all activities of daily living. Active music interventions, particularly singing, may improve mood, social behaviour, and quality of life. However, little is known about their effects on cognition, although some studies have provided promising results. The M4M project aims to fill this gap in research by measuring the effects of learning new songs on cognitive functioning. Specifically, M4M will examine memory for new songs in non-musician adults with AD after undergoing intensive versus minimal individual musical training based on singing novel songs.
Methods and analysis Home-dwelling adults with AD, 65 years or older, will receive 5 months of intensive intervention (2x/week) and 5 months of minimal intervention (1x/month). In a crossover design, participants will be randomized to receive either the intensive or minimal intervention first, with 2 months between the intervention periods. Participants will receive individual music lessons to learn new songs, provided by a music instructor with adequate training. The main outcomes will be measured at the beginning and end of each intervention period. General cognition will be measured with the Alzheimer’s Disease Assessment Scale – Cognitive (ADAS-cog) by an assessor blinded to the randomisation. Participants’ memory for music will be measured using the N400 component of electroencephalographic event-related potentials in response to music stimuli. Additional outcomes evaluated during intervention sessions include mood and musical performance observations. With 113 participants randomised, the trial will have 80% power to detect clinically meaningful effects. Relations between mood, memory for music, and cognitive abilities will be examined, with sex, age, AD stage, previous musical training, and education as covariates. M4M will be conducted in close collaboration between academic researchers, service providers, and service users to ensure relevance and applicability.
Ethics and dissemination Dissemination of findings will apply to local, national, and international levels. The study has been approved by the Regional Committees for Medical and Health Research Ethics in Norway.
Trial registration ClinicalTrials.gov, NCT06611878.
Strength and limitations
- Based on recent data suggesting that individuals with advanced dementia can learn new songs, our study moves beyond reminiscence-based therapy since the participants will be actively involved in musical training based on singing to learn novel songs
- The study focuses on home-dwelling older adults with dementia. This is becoming more and more important, as interventions that can prolong the period of independent living outside care facilities are urgently needed
- By using EEG technology that is portable, inexpensive, non-invasive, less demanding for participants than other brain imaging examinations, performed in a naturalistic setting, this study will reach people who are less mobile or live in remote areas, thus improving generalisability.
- As a multinational trial conducted in urban and rural settings in high- and middle-income countries, results will be relevant across diverse societies.
- Due to the nature of the intervention, participants cannot be blinded.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCTxxx (submitted, pending)
Funding Statement
This study has received funding from the Research Council of Norway (grant no. 344215).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study has been approved by the Regional Committees for Medical and Health Research Ethics in Norway.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Not applicable, as this is a study protocol.
